Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses

Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global health care emergency. Anti-SARS-CoV-2 serological profiling of critically ill COVID-19 patients was performed to determine their humoral response. Blood was collected from critically ill ICU patients, either COVID-19 positive (+...

Full description

Bibliographic Details
Main Authors: Douglas D. Fraser, Gediminas Cepinskas, Marat Slessarev, Claudio M. Martin, Mark Daley, Maitray A. Patel, Michael R. Miller, Eric K. Patterson, David B. O’Gorman, Sean E. Gill, Ian Higgins, Julius P. P. John, Christopher Melo, Lylia Nini, Xiaoqin Wang, Johannes Zeidler, Jorge A. Cruz-Aguado
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Pathophysiology
Subjects:
COVID-19
intensive care unit
humoral response
serology
immunoglobulins
outcome
Online Access:https://www.mdpi.com/1873-149X/28/2/14

Internet

https://www.mdpi.com/1873-149X/28/2/14

Similar Items